Patent 9795604 was granted and assigned to Pharmacyclics on October, 2017 by the United States Patent and Trademark Office.
Described herein are methods for treating and preventing graft versus host disease using ACK inhibitors. The methods include administering to an individual in need thereof an ACK inhibitor such as ibrutinib for treating and preventing graft versus host disease.